Literature DB >> 27539613

Evidence of H3 K27M mutations in posterior fossa ependymomas.

Marco Gessi1, David Capper2,3, Felix Sahm2,3, Kristin Huang2,3, Andreas von Deimling2,3, Stephan Tippelt4, Gudrun Fleischhack4, Daniel Scherbaum5, Joachim Alfer6, Björn-Ole Juhnke7, Katja von Hoff7, Stefan Rutkowski7, Monika Warmuth-Metz8, Lukas Chavez9, Stefan M Pfister9,10, Torsten Pietsch1, David T W Jones9, Dominik Sturm11,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27539613     DOI： 10.1007/s00401-016-1608-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  23 in total

1.  Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.

Authors:  Pooja Panwalkar; Jonathan Clark; Vijay Ramaswamy; Debra Hawes; Fusheng Yang; Christopher Dunham; Stephen Yip; Juliette Hukin; Yilun Sun; Matthew J Schipper; Lukas Chavez; Ashley Margol; Melike Pekmezci; Chan Chung; Adam Banda; Jill M Bayliss; Sarah J Curry; Mariarita Santi; Fausto J Rodriguez; Matija Snuderl; Matthias A Karajannis; Amanda M Saratsis; Craig M Horbinski; Anne-Sophie Carret; Beverly Wilson; Donna Johnston; Lucie Lafay-Cousin; Shayna Zelcer; David Eisenstat; Marianna Silva; Katrin Scheinemann; Nada Jabado; P Daniel McNeely; Marcel Kool; Stefan M Pfister; Michael D Taylor; Cynthia Hawkins; Andrey Korshunov; Alexander R Judkins; Sriram Venneti
Journal:  Acta Neuropathol       Date:  2017-07-21       Impact factor: 17.088

2.  EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.

Authors:  Jens-Martin Hübner; Torsten Müller; Dimitris N Papageorgiou; Monika Mauermann; Jeroen Krijgsveld; Robert B Russell; David W Ellison; Stefan M Pfister; Kristian W Pajtler; Marcel Kool
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

3.  Is H3K27me3 status really a strong prognostic indicator for pediatric posterior fossa ependymomas? A single surgeon, single center experience.

Authors:  Bahattin Tanrıkulu; Ayça Erşen Danyeli; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2020-02-05       Impact factor: 1.475

4.  H3 K27M mutations are extremely rare in posterior fossa group A ependymoma.

Authors:  Scott Ryall; Miguel Guzman; Samer K Elbabaa; Betty Luu; Stephen C Mack; Michal Zapotocky; Michael D Taylor; Cynthia Hawkins; Vijay Ramaswamy
Journal:  Childs Nerv Syst       Date:  2017-06-16       Impact factor: 1.475

Review 5.  The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.

Authors:  Alejandro Perez; Jason T Huse
Journal:  Curr Neurol Neurosci Rep       Date:  2021-11-24       Impact factor: 5.081

6.  Recurrent ACVR1 mutations in posterior fossa ependymoma.

Authors:  Drew Pratt; Calixto-Hope G Lucas; Pavalan Panneer Selvam; Zied Abdullaev; Courtney Ketchum; Martha Quezado; Terri S Armstrong; Mark R Gilbert; Antonios Papanicolau-Sengos; Mark Raffeld; Hyoyoung Choo-Wosoba; Priya Chan; Nicholas Whipple; MacLean Nasrallah; Mariarita Santi; Vijay Ramaswamy; Caterina Giannini; Timothy A Ritzmann; Richard G Grundy; Anna Burford; Chris Jones; Cynthia Hawkins; Sriram Venneti; David A Solomon; Kenneth Aldape
Journal:  Acta Neuropathol       Date:  2022-05-19       Impact factor: 15.887

Review 7.  The epigenetic dysfunction underlying malignant glioma pathogenesis.

Authors:  Sharvari Dharmaiah; Jason T Huse
Journal:  Lab Invest       Date:  2022-02-12       Impact factor: 5.502

8.  Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.

Authors:  Kristian W Pajtler; Ji Wen; Martin Sill; Tong Lin; Wilda Orisme; Bo Tang; Jens-Martin Hübner; Vijay Ramaswamy; Sujuan Jia; James D Dalton; Kelly Haupfear; Hazel A Rogers; Chandanamali Punchihewa; Ryan Lee; John Easton; Gang Wu; Timothy A Ritzmann; Rebecca Chapman; Lukas Chavez; Fredrick A Boop; Paul Klimo; Noah D Sabin; Robert Ogg; Stephen C Mack; Brian D Freibaum; Hong Joo Kim; Hendrik Witt; David T W Jones; Baohan Vo; Amar Gajjar; Stan Pounds; Arzu Onar-Thomas; Martine F Roussel; Jinghui Zhang; J Paul Taylor; Thomas E Merchant; Richard Grundy; Ruth G Tatevossian; Michael D Taylor; Stefan M Pfister; Andrey Korshunov; Marcel Kool; David W Ellison
Journal:  Acta Neuropathol       Date:  2018-06-16       Impact factor: 17.088

9.  Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.

Authors:  Michael Karremann; Gerrit H Gielen; Marion Hoffmann; Maria Wiese; Niclas Colditz; Monika Warmuth-Metz; Brigitte Bison; Alexander Claviez; Dannis G van Vuurden; André O von Bueren; Marco Gessi; Ingrid Kühnle; Volkmar H Hans; Martin Benesch; Dominik Sturm; Rolf-Dieter Kortmann; Andreas Waha; Torsten Pietsch; Christof M Kramm
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

10.  An H3F3A K27M-mutation in a sonic hedgehog medulloblastoma.

Authors:  Matthias Dottermusch; Nesrin Uksul; Ulrich J Knappe; Bernhard Erdlenbruch; Annika K Wefers
Journal:  Brain Pathol       Date:  2021-11-07       Impact factor: 7.611
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.